ZyVersa Therapeutics, Inc. Common Stock

Go to ZyVersa Therapeutics, Inc. Common Stock Website

$0.16

-0.02 (-8.96%)
Live
Previous Close

$0.1802

Day Range

$0.16 - $0.18

Previous Day Range

$0.18 - $0.22

Market Cap

$ USD

Day Vol.

21255

Previous Day Vol.

29292

Currency

USD

Primary Exchange

Nasdaq

ZYVERSA THERAPEUTICS INC...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

ZyVersa Therapeutics, a clinical-stage biopharmaceutical company, reported progress in its Phase 2a trial for Cholesterol Efflux Mediator™ VAR 200 in diabetic kidney disease and plans for its Inflammasome ASC Inhibitor IC 100 in obesity with metabolic complications. The company raised $0.8 million from warrant exercises and expects its current cash to fund operations on a month-to-month basis.

Related tickers: ZVSA.

Read Full Article

ZyVersa is on track to achieve key development milestones over the next 3 quarters.

Related tickers: ZVSA.

Read Full Article
Trending Tickers

Please sign in to view